Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel palladium-catalyzed carbonylation method for indole-3-formamide. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN108794412B details a high-yield base-promoted cyclization for triazoles, offering significant cost reduction in API manufacturing and superior purity profiles.
Patent CN113121472A reveals a room-temperature gold catalysis method for N-sulfonyl pyrrolidines, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN114920707B reveals a novel iodine-promoted route using DMF as a carbon source for high-purity triazole intermediates, offering significant cost and supply chain advantages.
Patent CN114195711B reveals a novel Pd-catalyzed carbonylation route for quinoline-4(1H)-one. This method offers significant supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel visible-light catalytic ruthenium complex enables efficient alkyne-aldehyde addition. Reduces energy costs and simplifies purification for pharmaceutical intermediate manufacturing.
Novel Te/I catalyzed one-step synthesis of 2-trifluoromethyl oxazoles. High purity pharma intermediates with reduced steps and cost-effective manufacturing.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API intermediates without heavy metals.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Patent CN109384753B discloses a catalyst-free rearrangement for 2-phenyl-3-methylbenzofurans, offering a greener, cost-effective route for pharmaceutical intermediates.
Efficient Mn-catalyzed cyclization method for complex heterocycles. High yield, green chemistry, scalable production for pharma intermediates.
Patent CN109400518B discloses a novel iodine-catalyzed one-pot synthesis of 6-arylbenzo[a]carbazoles. This method offers significant cost reduction and supply chain reliability for optoelectronic manufacturers.
Patent CN114751883B reveals efficient Pd-catalyzed carbonylation. Delivers high-purity benzofuran-3-carboxamide with supply chain stability.
Novel metal-free route for trifluoromethyl pyrazoles. Reduces cost and improves supply chain reliability for pharma intermediates. Efficient room temperature reaction.
Novel Pd-catalyzed carbonylation method for quinazolinones offers high yield and scalability for pharmaceutical intermediates.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
Novel heating-promoted synthesis eliminates metal catalysts for 2-trifluoromethyl quinoline. Offers green chemistry benefits and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Patent CN112299946B reveals iron-catalyzed olefin synthesis offering cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN114920707B reveals a novel DMF-based synthesis for 3-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and simplified supply chains.
Novel Pd-catalyzed carbonylation route for 2-CF3 quinazolinones using solid CO sources. Enhances purity and safety for API manufacturing supply chains.